Skip to main content
Equibles

Claude Nicaise

Board Member

Chemomab Therapeutics Ltd. (CMMB)

Chairman

Filana Therapeutics, Inc. (FLNA)

Board Member

Sarepta Therapeutics, Inc. (SRPT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Claude Nicaise

Claude Nicaise is recorded as Board Member at Chemomab Therapeutics Ltd. (CMMB), Chairman at Filana Therapeutics, Inc. (FLNA) and Board Member at Sarepta Therapeutics, Inc. (SRPT). Claude Nicaise was last confirmed as Board Member at Gain Therapeutics, Inc. (GANX) in a filing dated April 28, 2023. Filana Therapeutics, Inc. reported in an 8-K filed December 11, 2023 that Claude Nicaise was appointed Class II director, effective December 6, 2023.

“Dr. Nicaise and Mr. Gravier were appointed as Class II directors and will serve with a term expiring at the Company's 2026 annual meeting of stockholders.”
Filana Therapeutics, Inc. Form 8-K, filed December 11, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Chemomab Therapeutics Ltd.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Filana Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Sarepta Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.